Breaking
Dark Pool Bulls
Author

admin

Browsing
Investing

Newmont Withdraws from Mount Coolon Joint Venture, GBM Regains Full Ownership

Investing 2 Mins Read

GBM Resources (ASX:GBZ) announced it has regained ownership of the Mount Coolon gold project in Queensland following Newmont’s (TSX:NEM,NYSE:NEM,ASX:NEM) termination of a 2022 farm-in agreement.

GBM made the deal with Newcrest Mining before that company was acquired by Newmont in 2023.

Newmont’s withdrawal is part of its focus on divesting non-core assets to hone in on its more profitable and stable tier one operations. The company has made substantial adjustments to its portfolio this year.

GBM reacted positively to Monday’s (September 15) news, saying that regaining full ownership of the project aligns with its strategy to build a leading gold portfolio in the Drummond Basin.

“We are excited to regain 100 percent ownership, and our exploration team are enthusiastic about getting on the ground as we see significant upside on the Mt Coolon Tenure,” commented CEO Daniel Hastings.

Located within the Drummond Basin and near GBM’s Twin Hills and Yandan projects, Mount Coolon has a JORC resource of 6.65 million tonnes at 1.54 grams per tonne gold for 330,000 ounces of the metal.

Together, Twin Hills and Yandan hold a total resource of 1.84 million ounces of gold.

“With Twin Hills and Yandan nearby, we now control a substantial area of highly prospective ground within the Drummond Basin which provides GBM with the scale and flexibility to unlock significant value,’ Hastings added.

Newmont also announced the sale of its Coffee project in Yukon, Canada, to Fuerte Metals (TSXV:FMT,OTCQB:FUEMF) on Monday for potential total consideration of US$150 million. The company said that sale was also part of its efforts to streamline its portfolio and sharpen its focus on core operations.

On September 10, Newmont said it plans to voluntarily delist from the Toronto Stock Exchange.

Securities Disclosure: I, Gabrielle de la Cruz, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Keep Reading
Politics

Hakeem Jeffries’ 4-word answer to why he skipped Charlie Kirk vigil

Politics 2 Mins Read

House Minority Leader Hakeem Jeffries, D-N.Y., shared just a brief four-word response when a reporter asked him on Tuesday why he missed a congressional vigil for Charlie Kirk.

‘I had a meeting,’ Jeffries said when the matter was broached during his afternoon press conference.

House Speaker Mike Johnson, R-La., announced on Monday that Congress would hold a vigil later that evening to honor the conservative activist.

Kirk was assassinated last week when a gunman opened fire on him during a college campus speaking event in Utah.

Fox News Digital witnessed just a handful of House Democrats at the vigil, side by side with dozens of Republican lawmakers.

When asked why more Democrats did not attend, Jeffries said Tuesday, ‘I don’t know.’

‘I guess you’d have to talk to the individual Democrats as to what else was going on and why they were present or why they weren’t present,’ he said.

The vigil was held in the U.S. Capitol’s Statuary Hall in the 6 p.m. hour on Monday evening.

Democratic lawmakers who attended include Reps. Tom Suozzi, D-N.Y., Marie Gluesenkamp Perez, D-Wash., John Larson, D-Conn., Jimmy Panetta, D-Calif., Debbie Dingell, D-Mich., Chris Pappas, D-N.H., and Don Davis, D-N.C.

Notably absent were the top four House Democrats in senior leadership, including Jeffries.

Johnson, however, downplayed the lack of Democratic attendance in comments to reporters on Monday.

‘I honestly did not even see the composition of the group,’ he said when asked if he was disappointed in the number of Democrats who showed up.

‘I’m glad it was bipartisan, and I wish more had participated, and I’m not sure why they didn’t. So I don’t know what else we can do other than offer an all-member bipartisan vigil. And we’ve done that routinely for other things.’

Fox News’ Kelly Phares and Fox News Radio’s Ryan Schmelz contributed to this report.

This post appeared first on FOX NEWS

Keep Reading
Politics

Trump assassination attempt trial continues with more FBI testimony after rifle called ‘prepared to fire’

Politics 2 Mins Read

The federal trial of Ryan Routh, accused of attempting to assassinate President Donald Trump as he played golf in September 2024, resumes Tuesday with more FBI forensic experts scheduled to testify.

On Monday, jurors heard FBI Firearms and Toolmarks Examiner Erich Smith, who alleged the rifle found near the sixth hole of Trump International Golf Club was a Chinese-made Norinco SKS. Smith said the weapon was ‘in working condition’ when recovered, test-fired successfully at the FBI lab and was configured with a round in the chamber and the safety off — meaning it was ‘prepared to fire.’ 

He also testified the rifle’s serial number had been ‘obliterated in several places’ but could be partially restored.

Smith showed jurors the 7.62×39 mm full metal jacket rounds loaded in the rifle. 

‘Bullets are designed to put holes in things,’ he said. ‘It would have put a hole in something if it had hit the target.’

Routh, representing himself, cross-examined Smith about whether all SKS rifles are semi-automatic, whether test-firings were videotaped and whether the gun could have changed hands at a gun show before he obtained it. 

‘So, we’re just supposed to take your word for it?‘ Routh asked Smith. 

Smith replied: ‘That’s what happened.’ 

Trump-appointed Judge Aileen Cannon sustained prosecution objections when Routh strayed beyond the scope of testimony. 

The court also heard from FBI biologist Curtis Gaul, who testified about collecting potential DNA samples from the rifle grip, a glove, zip ties and other items found. Routh cross-examined briefly, asking where the glove was found and whether Gaul knew who removed the rifle’s scope.

Cannon cut off questioning several times, urging both prosecutors and Routh to keep examinations moving. 

Jurors appeared confused during parts of Gaul’s testimony, as prosecutors referenced exhibit numbers without always displaying them. Meanwhile, Routh was seen leaning forward, taking notes and staring intently when fingerprints reportedly matching his own were displayed on a screen.

When court resumes Tuesday morning, prosecutors are expected to call FBI biologist Kara Gregor, followed by additional FBI specialists in digital forensics and supervisory roles as they continue building their case against Routh.

This post appeared first on FOX NEWS

Keep Reading
Politics

Patel defends FBI pull-up test after Hirono decries it as gender bias in Senate showdown

Politics 3 Mins Read

Democrat Sen. Mazie Hirono of Hawaii clashed with FBI Director Kash Patel during a heated Senate Judiciary Committee hearing on Tuesday, questioning agency firing and counterterrorism priorities and even calling the bureau’s physical fitness requirements ‘harsh’ for applicants.

In an exclusive statement to Fox News Digital, Patel said, ‘Americans expect their FBI agents to be capable, resilient and ready to protect them.

‘That’s why, under my watch, every field office is receiving more trained agents, more boots on the ground and a renewed commitment to getting out from behind the desks and back onto the streets where they’re needed most. We’re rebuilding a bureau that earns the public’s confidence by being present, prepared and physically ready to do the job.’

The most viral clash came when Hirono pressed Patel on fitness standards.

‘One question I had is that you are now requiring applicants to be able to do a certain kind of pull-ups, which a lot of women cannot because of physiological differences. Are you requiring these kinds of pull-ups?’ Hirono asked.

Patel didn’t budge.

‘We are requiring everybody to pass the 1811 standards at BFTC. If you want to chase down a bad guy, excuse me, and put him in handcuffs, you had better be able to do a pull-up.’

Hirono replied, ‘There are concerns about whether or not being able to do these kinds of harsh pull-ups is really required of FBI agents.’

Patel interjected, ‘Doing one pull-up is not harsh, and there are always medical exemptions to that.’

According to the FBI recruitment website, ‘Starting in November 2025, pull-ups will be a required event for all candidates.’ For male recruits, 2-3 pull-ups are now a required minimum alongside the traditional Physical Fitness Test (PFT). For female candidates, one pull-up is the required minimum. 

Any additional pull-ups count to a recruit’s overall PFT score, with the maximum points received for 20 or more pull-ups capped at 10.

The White House’s official X account, @RapidResponse47, shared the exchange in a now-viral clip on X.

Beyond fitness standards, Hirono accused Patel of being loyal to Trump rather than the FBI.

‘Your most significant qualification … was your 100% loyalty to President Trump. And I fear that continues to be the motivating factor in your position as FBI director.’

Patel rejected that claim. 

‘That is an entire falsehood. You can delete my 16 years of government service to multiple administrations all you want. … There was no loyalty then. There’s no loyalty now to anything but the Constitution.’

Patel also used the hearing to share the bureau’s wins under his leadership. He pointed to 409 cyber arrests this year and 169 convictions, a 42% increase from the same time last year.

The FBI and the office of Sen. Mazie Hirono did not immediately respond to Fox News Digital’s request for comment.

This post appeared first on FOX NEWS

Keep Reading
Politics

Social Security pushes back on Warren, touts transparency and service under Trump

Politics 2 Mins Read

The Social Security Administration is pushing back against Sen. Elizabeth Warren, D-Mass., after she accused the agency of removing key data and covering up dysfunction.

In a Sept. 16, 2025 letter and data report shared exclusively with Fox News Digital, SSA Commissioner Frank J. Bisignano claimed Warren’s analysis was inaccurate. 

He said the agency is more transparent and performing better under the Trump administration than it did under the prior administration. The documents reflect SSA’s position and have not been independently verified.

‘SSA currently reports nearly three times the number of data elements on the performance webpage under the Trump Administration (30) than it did under the Biden Administration (11),’ Bisignano wrote.

‘These facts conclusively demonstrate that you are wrong in alleging a lack of transparency.’

He also pushed back on Warren’s charge of a cover-up, saying SSA has made improvements in customer service, including ‘shorter wait times on the phones and in offices, as well as reduced backlogs.’ Bisignano said 81 percent of performance measures are better than before, with the rest about the same.

According to SSA’s data, average phone wait times dropped from 29 minutes in 2024 to 16 minutes in 2025, with August down to just 9 minutes.

Pending disability determinations fell from nearly 1.2 million in August 2024 to about 907,000 a year later. Disability claim processing sped up from 231 days to 217 days. SSA reports retirement and survivor claims were processed on time 87% of the time in August 2025.

Bisignano wrote that the agency’s goal is to become a ‘digital-first’ operation that runs efficiently and serves people whether they call, visit an office or use the website. He said constant monitoring of key performance indicators is part of that effort.

He also urged Warren to work with SSA instead of spreading what he called ‘fearmongering and reckless lies that Social Security is going away.’

‘The time has come to stop weaponizing Social Security,’ he wrote. ‘The American people do not want a Social Security War Room. They want their leaders to protect and preserve Social Security, just as President Trump has promised.’

This post appeared first on FOX NEWS

Keep Reading
Politics

Trump and first lady to get King Charles royal treatment at Windsor Castle

Politics 3 Mins Read

President Donald Trump and first lady Melania Trump will receive a full royal welcome from King Charles III following their arrival to Windsor Castle on Tuesday night.

Wednesday’s festivities will kick off with Trump, the first lady and several top U.S. officials participating in a carriage procession with the king, queen and other members of the royal family. Ahead of the couple’s arrival, hundreds of staff worked through the halls and grounds of the nearly 1,000-year-old castle to ensure the monarch welcomed the couple in true royal fashion.

Trump is set to ride in the foremost carriage along with King Charles, while Melania will ride in a following carriage with the queen. Secretary of State Marco Rubio, Treasury Secretary Scott Bessent, White House chief of staff Susie Wiles and special envoy Steve Witkoff will also ride in follow-up carriages.

Ahead of his visit, Trump hailed the ‘great honor’ of being hosted by his ‘friend’ at ‘the ultimate’ Windsor Castle for his second state visit, the U.K.’s Standard reported.

‘My relationship is very good with the U.K., and Charles, as you know, who’s now king, is my friend,’ Trump told reporters, quoted by the outlet. ‘It’s the first time this has ever happened where somebody was honored twice. So, it’s a great honor.’

‘And this one’s at Windsor,’ Trump added. ‘And I don’t want to say one’s better than the other, but they say Windsor Castle is the ultimate, right? So, it’s going to be nice.’

‘Primarily it’s to be with Charles and Camilla,’ he continued. ‘They’ve been friends of mine for a long time, long before he was king, and it’s an honor to have this king.’

The centerpiece of Trump’s visit is set to be the banquet in St. George’s Hall. The Waterloo Table, about half the length of a football field, can seat up to 160 guests. The Associated Press reported it takes five full days to set the table, which is laid with more than 4,000 pieces, including 200-year-old silver.

The visit comes as the U.S. and U.K. continue trade negotiations, though the White House has not indicated that any deals will be announced during the event.

Trump is the first U.S. president to be invited for two state visits by a British monarch. The late queen hosted him and Melania in 2019 during his first administration.

Fox News’ Stephanie Nolasco contributed to this report

This post appeared first on FOX NEWS

Keep Reading
Business

LimeWire acquires Fyre Festival, asking ‘What Could Possibly Go Wrong?’

Business 2 Mins Read

LimeWire, the filesharing service that set the internet ablaze in the 2000s before being shut down for copyright infringement, said Tuesday that is acquiring the rights to Fyre Festival.

And it appreciates the irony.

‘LimeWire Acquires Fyre Festival Brand — What Could Possibly Go Wrong?’ the company titled its news release.

LimeWire said it would “unveil a reimagined vision for Fyre — one that expands beyond the digital realm and taps into real-world experiences, community, and surprise.” The company offered no additional details about how the Fyre brand will be relaunched.

For years, LimeWire operated as a competitor to fellow file-sharing platform Napster before being effectively shut down by a court ruling in 2010 after a judge ruled it had facilitated large-scale copyright violations. In 2022, Austrian brothers Julian and Paul Zehetmayr bought LimeWire’s intellectual property and turned it into an NFT service.

Fyre Festival was a 2017 music festival that saw ticket buyers spend thousands of dollars for a weekend in the Bahamas only to be met with a logistics debacle that included portable bathrooms taking the place of regular toilets, and low-budget food options that betrayed promises of celebrity chef fare. Organizer Billy McFarland was later convicted of fraud and sentenced to six years in prison.

“Fyre became a symbol of hype gone wrong, but it also made history,” LimeWire CEO Julian Zehetmayr said. “We’re not bringing the festival back — we’re bringing the brand and the meme back to life. This time with real experiences, and without the cheese sandwiches.”

LimeWire said its bid was backed by Maximum Effort, the creative agency co-founded by the actor and entrepreneur Ryan Reynolds.

“Congrats to LimeWire for their winning bid for Fyre Fest,” Reynolds said in the release. “I look forward to attending their first event but will be bringing my own palette of water.”

This post appeared first on NBC NEWS

Keep Reading
Investing

Crypto Market Update: Bitcoin ETF Inflows Hit US$2.3 Billion as Traders Bet on Fed Easing

Investing 6 Mins Read

Here’s a quick recap of the crypto landscape for Monday (September 15) as of 9:00 p.m. UTC.

Get the latest insights on Bitcoin, Ethereum and altcoins, along with a round-up of key cryptocurrency market news.

Bitcoin and Ethereum price update

Bitcoin (BTC) was priced at US$115,303, a 0.3 percent decrease in 24 hours. Its lowest valuation of the day was US$114,509, and its highest was US$115,549.

Bitcoin price performance, September 15, 2025.

Chart via TradingView.

CrypNuevo projects that Bitcoin may dip to US$112,000 to US$113,000 this week before presenting new swing long opportunities in altcoins like Chainlink and Ripple. Profit taking on Bitcoin longs is planned to start around US$119,200, anticipating market volatility and liquidity shifts around the US Federal Reserve’s meeting.

Ether (ETH) was priced at US$4,494.71, a decrease of 2.6 percent over the past 24 hours. Its lowest valuation on Monday was US$4,476.73, and its highest was US$4,538.16.

Altcoin price update

  • Solana (SOL) was priced at US$232.85, a decrease of 4 percent over the last 24 hours. Its lowest valuation on Monday was US$230.63, and its highest level was US$236.56.
  • XRP was trading for US$2.99, down by 1.4 percent in the past 24 hours, and at its lowest valuation of the day. Its highest value for Monday was US$3.03.
  • SUI (Sui) was valued at US$3.49, down by 5.6 percent in the past 24 hours. Its lowest price point of the day was US$3.47, and its highest price was US$3.53.
  • Cardano (ADA) was priced at US$0.8594, down by 3.3 percent over 24 hours. Its lowest valuation on Monday was US$0.8548, and its highest was US$0.8679.

Today’s crypto news to know

Bitcoin ETF inflows fuel bets on Q4 rally

Spot Bitcoin exchange-traded funds (ETFs) in the US have seen a staggering US$2.3 billion in inflows over the past week, a sign that institutional demand is surging just ahead of a critical Fed interest rate decision.

Traders widely expect the central bank to cut rates on Wednesday (September 17), a move that could boost risk assets across the board. Analysts say that Bitcoin, which has slipped nearly 8 percent since peaking at US$124,128 in August, may be poised for another leg higher if liquidity conditions ease.

“We’re only halfway through what could be a very powerful Q4 rally,” said Sean Dawson, head of research at Derive, who projects Bitcoin could reach US$140,000 by year end. Options data shows heavy positioning at US$140,000 to US$200,000 December calls, with some putting cycle tops as high as US$250,000 if flows persist.

PayPal plans crypto integration

PayPal (NASDAQ:PYPL) has introduced PayPal links, personalized one-time links generated within the PayPal app that can be shared via text, email or chat. According to the company, the move will make it more convenient for users to send digital currencies like Bitcoin, Ether and PYUSD to PayPal and its sister service, Venmo.

PayPal links will initially launch in the US, with plans to expand to the UK, Italy and other markets later this year.

Robinhood to launch venture fund for retail investors

Robinhood Markets (NASDAQ:HOOD) has filed with the US Securities and Exchange Commission to launch a venture fund accessible to retail investors, according to a Monday company announcement. The fund would offer exposure to startup and private company investments, opportunities typically restricted to institutions.

“For decades, wealthy people and institutions have invested in private companies while retail investors have been unfairly locked out. With Robinhood Ventures, everyday people will be able to invest in opportunities once reserved for the elite,” said Robinhood Chairman and CEO Vlad Tenev.

The announcement highlights the disparity in investment opportunities for retail and institutional investors, explaining that the fund, Robinhood Ventures Fund I (RVI), would address this by expanding access to the private market.

This initiative builds on Robinhood’s previous launch of private tokenized stocks in the EU, which allows US retail investors to participate in private markets and gain exposure to companies before they go public. RVI plans to invest long term in a focused portfolio of private companies across various sectors.

Base teases native token launch and Solana bridge

Coinbase Global’s (NASDAQ:COIN) Layer 2 blockchain, Base, teased the potential launch of a native token at its BaseCamp event, a major event for the network. While details have not been confirmed, the news hints at a possible governance or utility token to expand Base’s ecosystem and incentivize user participation.

“As we begin this exploration, we’re sharing this shift in philosophy early as part of our commitment to building in the open, but we have no definitive plans to share at this time,” the company said following the event.

During the announcement, Base also shared that an open-source bridge to connect Base and Solana is in progress; it would enable cross-chain interoperability between the two ecosystems. Base also discussed new tools to support developers and users, including Base Batches 002 to help transform projects from concept to launch, and a Base Build dashboard designed to help builders scale and monetize their work.

France threatens to block EU crypto license “passporting”

France’s financial regulator is raising the stakes in Europe’s battle over crypto oversight, warning it could block firms licensed in other EU countries from operating domestically. According to a Reuters exclusive, the Autorité des Marchés Financiers (AMF) says some companies are “shopping around” for jurisdictions with looser standards under the bloc’s new MiCA framework, then using those approvals to “passport” their services across the EU.

Alongside Italy and Austria, France is pressing for the European Securities and Markets Authority to take charge of supervising major crypto players. AMF Chief Marie-Anne Barbat-Layani described the potential rejection of EU licenses as an “atomic weapon” that Paris could wield if it sees regulatory gaps.

Analysts worry fragmented national approaches could undermine investor protection and financial stability.

Notably, exchanges like Coinbase and Gemini have already secured MiCA licenses in Luxembourg and Malta, raising questions about uneven enforcement across the bloc.

Ethereum Foundation pivots to privacy-first roadmap

The Ethereum Foundation, a non-profit organization that supports Ethereum and related technologies, has unveiled a new initiative to make privacy a default feature across the blockchain’s ecosystem.

Rebranding its Privacy & Scaling Explorations team as the “Privacy Stewards of Ethereum,” the foundation has laid out plans for private transfers, confidential DeFi and protected governance mechanisms within the next six months.

“Our vision is to make privacy on Ethereum the norm rather than the exception,” the group said in a statement, arguing that users and institutions will otherwise drift to centralized alternatives. The roadmap also extends beyond transactions, with proposals to embed privacy in wallets, identity tools, and data portability.

Co-founder Vitalik Buterin has long championed stronger safeguards. His recent comments about risks from artificial intelligence-driven data leakage have reinforced the urgency of integrating privacy at the protocol level.

Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.

Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Keep Reading
Investing

Robotics Stocks: 10 Biggest Companies in 2025

Investing 9 Mins Read

As the robotics industry prepares for significant technological advances in artificial intelligence (AI), it’s no surprise that the top robotics stocks are gaining attention.

Chief executive officer of Hangzhou Unitree Technology, Wang Xingxing, told the World Robots Conference in Beijing in August 2025 that the industry could be about one to three years away from a breakthrough comparable to the ChatGPT moment. He also expressed optimism about the future, predicting that at least one company might develop a general-purpose robotic AI model by the end of 2025.

While these transformative AI advancements promise to reshape robotics broadly, current market data shows that the automotive industry continues to drive a large share of robotics orders. However, according to data from the Association for Advancing Automation, rapid growth in demand from the food and consumer products and life science sectors was also notable in 2024.

Surgical robots are increasingly being used in a variety of surgery types, such as cardiac and spinal, allowing for better patient outcomes.

With technological breakthroughs just on the horizon and diverse sectors driving demand, now is an opportune moment to explore the top robotics stocks poised to capitalize on this rapidly evolving industry.

10 largest robotics stocks

This list of top robotics stocks by market cap was compiled using TradingView’s stock screener. All market cap and share price information was current as of September 3, 2025.

1. NVIDIA (NASDAQ:NVDA)

Share price: US$170.62
Market cap: US$4.15 trillion

NVIDIA’s robotics business has surged ahead in 2025 with major technology releases and expanding industry partnerships, establishing it as a core infrastructure provider for robotic intelligence. Its Jetson Thor platform offers 7.5 times more compute and 3.5 times greater energy efficiency than its predecessor.

The company is driving physical AI, the fourth wave of the AI revolution, through its Cosmos model, which allows developers to train robots for diverse scenarios, a critical component to advancing autonomous vehicles and humanoid robots.

2. Tesla (NASDAQ:TSLA)

Share price: US$334.09
Market cap: US$1.08 trillion

Tesla’s robotics business is becoming increasingly central to its CEO, Elon Musk, who claims its Optimus humanoid robot will eventually become the company’s core value driver. The company is focused on developing and scaling Optimus, although its goal of producing 5,000 in 2025 is reportedly behind schedule as of July. Tesla is aiming to produce 1 million units annually by 2030.

The long-term goal is to achieve fully autonomous robots that can be deployed across manufacturing, logistics, elder care and residences, which it detailed in its Master Plan IV released in early September.

3. Thermo Fisher Scientific (NYSE:TMO)

Share price: US$484.55
Market cap: US$182.97 billion

Thermo Fisher Scientific is a medical device company that is one of the world’s most respected brands in healthcare, scientific research, safety and education. Its products and services cover a broad range of high-end analytical instruments, chemistry and consumable supplies, automated laboratory robotics and software designed primarily for medical researchers, clinicians and scientists.

In June 2025, Thermo Fisher Scientific partnered with Cellular Origins, which owns the Constellation robotic manufacturing platform, to scale up late-stage trials and commercial production of cell and gene therapies.

Outside the life science sector, the company launched the Vulcan Automated Lab in early 2025, integrating robotic sample handling, AI and advanced electron microscopy to improve semiconductor development.

4. Qualcomm (NASDAQ:QCOM)

Share price: US$157.28
Market cap: US$169.71 billion

Qualcomm’s specialty is designing and manufacturing semiconductors, software and wireless telecommunications products. In recent years, the company has devoted attention to AI-related technologies such as on-device AI, edge cloud AI and technologies that combine 5G and AI. These technologies also underlie Qualcomm’s advancements in the robotics space.

Qualcomm’s Snapdragon platform is a high-performance, low-power system-on-a-chip designed for AI, 5G connectivity and real-time processing used in a variety of sectors, including in robotics.

The Qualcomm Robotics RB6 Platform supports next-generation robotics and intelligent machines. According to the company, some applications include autonomous mobile robots, delivery robots, highly automated manufacturing robots, urban air mobility aircrafts and autonomous defense solutions.

It also has the Flight RB5 5G platform that specifically targets autonomous drones and flying robots, integrating multiple sensors, multiple cameras, 5G and Wi-Fi 6 connectivity to enable advanced navigation and AI-driven control.

5. Boston Scientific (NYSE:BSX)

Share price: US$107.53
Market cap: US$159.33 billion

Boston Scientific is a medical device company leading in cardiac and electrophysiology robotics and advanced ablation systems.

Its OPAL HDx mapping systems allow physicians to precisely navigate within the heart through 3D mapping, position tracking and more. It employs the company’s FARAPULSE Pulsed Field Ablation system, which generated over US$1 billion in revenue in its first year and now holds expanded US Food and Drug Administration (FDA) approval for both pulmonary vein and posterior wall ablation.

Strategic acquisitions since 2024 include Silk Road Medical, Axonics, Bolt Medical and SoniVie, giving the company access to a wealth of product offerings to address patient needs and create new revenue streams.

6. Intuitive Surgical (NASDAQ:ISRG)

Share price: US$441.18
Market cap: US$158.15 billion

A leader in surgical robotics, Intuitive Surgical is the company behind the da Vinci minimally invasive surgical system. The original da Vinci system gained FDA approval in 2000, making it the first completely robotic surgical system to receive clearance from the FDA.

Intuitive Surgical now provides a suite of its da Vinci robotics-assisted surgical systems to doctors and hospitals, and they are used by surgeons across all 50 US states and 72 countries around the world.

New products, including the Ion robot for lung biopsies and the SureForm SP stapler, are experiencing unprecedented growth. Their AI-driven features contribute to reducing error rates and enhancing outcomes.

7. Stryker (NYSE:SYK)

Share price: US$388.56
Market cap: US$148.55 billion

Stryker is another leading medical technology company. It develops medical equipment, instruments and surgical robotics for healthcare systems worldwide. Its surgical robotics systems incorporate health data and AI to improve health outcomes for patients.

Stryker’s Mako 4 robotic arm system for assisted joint replacement surgery can be used in partial knee, total knee, hip and spine surgeries, and a version for shoulder surgeries was recently introduced. The company showcased an upgrade to its Mako Total Hip system during the American Academy of Orthopaedic Surgeons’ 2025 Annual Meeting in San Diego in March.

Stryker launched Ortho Q Guidance, its surgical guidance system for knee and hip procedures, in July 2023. The platform can be integrated into robotics technology.

8. Honeywell International (NASDAQ:HON)

Share price: US$214.00
Market cap: US$135.87 billion

Engineering and technology company Honeywell International develops and manufactures technological solutions for a variety of sectors, including energy, security, safety, productivity and global urbanization. Its four business divisions are: aerospace, building technologies, performance materials and technologies, and safety and productivity solutions.

For more than a quarter century, Honeywell’s smart robotics technologies, including autonomous mobile robots and order-picking AI-powered robots, have provided warehouse automation solutions targeting transport, order picking, palletizing and depalletizing.

In 2025, Honeywell announced a strategic partnership with Teradyne Robotics, a division of Teradyne (NASDAQ:TER), to deliver end-to-end automation solutions using Teradyne’s autonomous mobile robots and collaborative robots and Honeywell’s software.

9. Medtronic (NYSE:MDT)

Share price: US$92.25
Market cap: US$118.33 billion

Medtronic is one of the largest medical device manufacturing companies in the world. The firm’s technologies include cardiac devices, surgical robotics, insulin pumps, surgical tools and patient monitoring systems.

Medtronic’s Hugo robotic-assisted surgery system is a modular platform with four independent robotic arms, designed to improve precision, flexibility and surgeon ergonomics in minimally invasive soft tissue surgeries like urology and gynecology.

It features 3D high-definition visualization, advanced AI-powered analytics and an open console for better surgeon communication. Hugo offers a cost-effective and adaptable alternative to traditional systems and has been commercially used in North America since 2023.

10. Texas Instruments (NASDAQ:TXN)

Share price: US$195.74
Market cap: US$4.78 billion

Texas Instruments is a leading semiconductor manufacturer whose robotics business focuses on supplying high-precision analog chips, sensors, embedded processors and motor control solutions for industrial automation, factory robots, automotive robotics and smart devices.

Texas Instruments partnered with KUKA in April 2025 to jointly advance next-generation industrial robotics. The collaboration focuses on integrating TI’s precision analog sensors and real-time motor control chips into KUKA’s robot arms and automation platforms, resulting in safer, more energy-efficient and adaptive robots for smart factories and logistics.

FAQs for robotics stocks

What is robotics?

In simple terms, robotics is defined as the branch of technology that deals with the design, construction, operation and application of robots. The field has subsets such as automation and AI.

Both automation and robotics have been used interchangeably, but these terms have certain differences. Automation is the process of using technology to carry out specific tasks, and not all robots are designed for automation. That said, most robots are, especially those with industrial uses.

What are the five major fields of robotics?

The five major fields of robotics are: operator interface, mobility, manipulator and effectors, programming and sensing and perception.

Operator interface is better described as human-robot interface — it’s the means by which humans can communicate commands to a robot. This might be in the form of a touchscreen on a control panel.

Mobility refers to the ability of a robot to move in its environment, while manipulators and effectors allow the robot to interact with its environment. Think of an autonomous mobile robot moving around a warehouse to stack inventory on a pallet. For its part, programming involves the language used to communicate commands to the robot.

Meanwhile, sensing and perception allows the robot to acquire information about its environment and perform tasks based on that information. This is important for autonomous vehicle technology.

How can I invest in robotics?

For investors looking to enter the robotics sector, large companies like the ones listed above may be a good place to start. Those with a broader approach who would rather put their money into the sector as a whole rather than in a single company may want to consider exchange-traded funds focused on robotics.

Is Boston Dynamics public?

Boston Dynamics is a private mobile robotics engineering firm that specializes in building robots and software for human simulation. Originally part of the Massachusetts Institute of Technology, Boston Dynamics is held by Hyundai (80 percent) and Softbank Group (TSE:9984) (20 percent).

Can I buy stock in Miso Robotics?

Miso Robotics is a privately held company, which means it is not listed on any stock exchange. The company develops and manufactures AI-driven robots, including automatic fry cook Flippy, that help restaurants with food preparation.

Water, hygiene and infection prevention company Ecolab (NYSE:ECL) has partnered with Miso Robotics “to explore new opportunities to enhance food safety, hygiene, and efficiency in the food industry through automation and digital solutions.”

Securities Disclosure: I, Melissa Pistilli, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Keep Reading
Investing

Lobe Sciences Ltd. to Attend the ArcStone-Kingswood Growth Summit 2025 in Toronto

Investing 2 Mins Read

lobe sciences ltd. (CSE: LOBE,OTC:LOBEF) (OTCQB: LOBEF) (FSE: LOBE.F) (‘Lobe Sciences’ or the ‘Company’) a clinical stage biopharmaceutical company focused on developing products to treat diseases with significant unmet medical needs is pleased to announce its participation in the upcoming ArcStone-Kingswood Growth Summit in Toronto, taking place at the St. Regis Toronto on September 18, 2025. Dr. Frederick D Sancilio, CEO of lobe sciences ltd. will be presenting the company’s recent milestones and future growth strategy.

The ArcStone-Kingswood Growth Summit will be hosting over 20 companies and a curated group of investors for a full day of pre-arranged, targeted 1-on-1 meetings, panel discussions and networking opportunities.

Alongside the schedule of pre-booked meetings matching investors with appropriate projects, the conference program will provide amble opportunities to mix and mingle with the industry professionals and catch up on key industry developments.

Interested investors who would like to attend the ArcStone-Kingswood Growth Summit can register to request for a free invitation here.

About ArcStone Securities and Investments Corp.

ArcStone Securities and Investments Corp. is a diversified financial services firm with offices in Toronto and New York. Our firm specializes in providing bespoke solutions to mid-market companies worldwide, with a particular focus on cross-border transactions between Canada and the United States. Our partnership with Kingswood US enhances our ability to offer a full spectrum of financial services to our clients.

About Kingswood US

Kingswood US is a mid-market investment bank with a strong retail equity capital markets franchise and deep-rooted investment bank. The firm is dedicated to providing comprehensive financial services, including investment banking, wealth management, and capital raising, to clients across the United States.

About lobe sciences ltd.

Lobe Sciences Ltd. is a clinical stage biopharmaceutical company focused on developing novel therapies for rare neurological and hematological conditions. The company operates through two subsidiaries:

  • Altemia, Inc. is addressing sickle cell disease with two complementary assets: a medical food currently in early-stage distribution, and S-100, a patent-pending therapeutic candidate designed to treat the underlying pathology of the disease.

Lobe’s pipeline is differentiated by intellectual property, clinical momentum, and a strategic focus on high-value, underserved markets.

For additional Information, please contact:

lobe sciences ltd.
info@lobesciences.com
www.lobesciences.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/265683

News Provided by Newsfile via QuoteMedia

This post appeared first on investingnews.com

Keep Reading